Enable Injections CEO and leadership

Mr. Michael Hooven D. is a President and Chief Executive Officer at Enable Injections and is based in United States.

Don Kirkpatrick is a Chief Operating Officer at Enable Injections and is based in Cincinnati, Ohio. He has worked as Sr. Director, China Manufacturing Operations at Arrow International; Vice President, Operations & Product Development at CORPAK MedSystems; and R&D Engineer at TELEFLEX INC. Don studied at Boston College Carroll School of Management between 1996 and 1999 and University of Massachusetts, Lowell.

Mr. Matthew J. Huddleston serves as Executive Vice President and Chief Technology Officer for Enable Injections. He is an experienced medical device professional with over 15 years’ experience in start-up environments with particular emphasis in project management, design, development, manufacturing, regulatory and intellectual property. He has several issued and pending patents in the medical device field including soft tissue and cardiovascular fixation devices and delivery instruments, histologic automated embedding systems, laparoscopic visualization devices, and automatic injection devices. He is a professional engineer and a licensed patent agent. Mr. Huddleston holds a Bachelor of Science in Mechanical Engineering from Purdue University and a Master of Science in Biomedical Engineering from The Ohio State University.

Tim Flaherty was named Executive Vice President and Chief Financial Officer of Enable Injections in February 2015. Tim brings 25 years of public and private company experience in finance, accounting, human resource, and information technology management. He is responsible for the finance, accounting, information technology, and will play a key role in business development and strategy of Enable Injections. Prior to Enable Injections, Tim served as North American CFO for Bonfiglioli, Inc., a leading billion dollar global Italian owned company in the power transmission market. He played a key role in developing the finance, accounting, human resource, and information technology departments to allow the North American business units to scale from $68 million to $140 million in four years. Tim was nominated for CFO of the year in 2014 by the Cincinnati Business Courier in the large private company category for his achievements at Bonfiglioli, Inc. Prior to Bonfiglioli, Tim held several executive financial roles in large publicly traded companies and small private companies. The companies that Tim worked for included ArvinMeritor (NYSE:ARM), Ametek (NYSE:AME), and AtriCure /Enable Medical (NASD: ATRC). Some of his responsibilities included: Merger and Acquisitions, IPO experience, plant consolidations, shared-service operations, multi-location oversight, SEC Reporting, system implementations, scalability, cost and risk controls, internal controls, Sox compliance, financial modeling, business development, strategy, budgeting, forecasting, due diligence, cash management and treasury, etc. Tim earned his accounting degree from the University of Kentucky and his Master of Business Administration from Xavier University, Cincinnati, OH. Tim and his wife, Karin, have been married 16 years and have two children.

Mr. Michael Hooven D. is a President and Chief Executive Officer at Enable Injections and is based in United States.

Mr. Michael Hooven D. is a President and Chief Executive Officer at Enable Injections and is based in United States.